Report #2841911

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Havrix - Delayed second dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug administration duration too long in a 60-year-old female patient who received HAV (Havrix) for prophylaxis. Previously administered products included Havrix (received 1st dose in 2009). On an unknown date, the patient received the 2nd dose of Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced drug administration duration too long (Verbatim: Havrix - Delayed second dose.). The outcome of the drug administration duration too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-MAY-2025 The pharmacist mentioned that a patient received the first Havrix vaccine in 2009 and then a second dose of Havrix in 2023. The Healthcare professional asked if the patient should received extra doses. The patient received 2nd dose of Havrix, later than the recommended interval, which led to lengthening of vaccinations schedule.